These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15172406)

  • 1. Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction.
    Aguilar D; Skali H; Moyé LA; Lewis EF; Gaziano JM; Rutherford JD; Hartley LH; Randall OS; Geltman EM; Lamas GA; Rouleau JL; Pfeffer MA; Solomon SD
    J Am Coll Cardiol; 2004 Jun; 43(11):2015-21. PubMed ID: 15172406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction.
    Shah AM; Pfeffer MA; Hartley LH; Moyé LA; Gersh BJ; Rutherford JD; Lamas GA; Rouleau JL; Braunwald E; Solomon SD
    Am J Cardiol; 2010 Oct; 106(7):911-6. PubMed ID: 20854949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
    Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
    Velazquez EJ; Francis GS; Armstrong PW; Aylward PE; Diaz R; O'Connor CM; White HD; Henis M; Rittenhouse LM; Kilaru R; van Gilst W; Ertl G; Maggioni AP; Spac J; Weaver WD; Rouleau JL; McMurray JJ; Pfeffer MA; Califf RM;
    Eur Heart J; 2004 Nov; 25(21):1911-9. PubMed ID: 15522470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate alcohol consumption is associated with reduced long-term cardiovascular risk in patients following a complicated acute myocardial infarction.
    Brügger-Andersen T; Pönitz V; Snapinn S; Dickstein K;
    Int J Cardiol; 2009 Apr; 133(2):229-32. PubMed ID: 18372063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
    Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
    Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of inflammation on the relationship among alcohol consumption, mortality, and cardiac events: the health, aging, and body composition study.
    Maraldi C; Volpato S; Kritchevsky SB; Cesari M; Andresen E; Leeuwenburgh C; Harris TB; Newman AB; Kanaya A; Johnson KC; Rodondi N; Pahor M
    Arch Intern Med; 2006 Jul; 166(14):1490-7. PubMed ID: 16864759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol drinking and risk of hospitalization for heart failure with and without associated coronary artery disease.
    Klatsky AL; Chartier D; Udaltsova N; Gronningen S; Brar S; Friedman GD; Lundstrom RJ
    Am J Cardiol; 2005 Aug; 96(3):346-51. PubMed ID: 16054455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials.
    Frazier CG; Alexander KP; Newby LK; Anderson S; Iverson E; Packer M; Cohn J; Goldstein S; Douglas PS
    J Am Coll Cardiol; 2007 Apr; 49(13):1450-8. PubMed ID: 17397674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
    Lewis EF; Velazquez EJ; Solomon SD; Hellkamp AS; McMurray JJ; Mathias J; Rouleau JL; Maggioni AP; Swedberg K; Kober L; White H; Dalby AJ; Francis GS; Zannad F; Califf RM; Pfeffer MA
    Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
    Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction.
    Jose P; Skali H; Anavekar N; Tomson C; Krumholz HM; Rouleau JL; Moye L; Pfeffer MA; Solomon SD
    J Am Soc Nephrol; 2006 Oct; 17(10):2886-91. PubMed ID: 16928807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binge drinking and mortality after acute myocardial infarction.
    Mukamal KJ; Maclure M; Muller JE; Mittleman MA
    Circulation; 2005 Dec; 112(25):3839-45. PubMed ID: 16365208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of outcomes among moderate alcohol drinkers before acute myocardial infarction to effect of continued versus discontinuing alcohol intake after the infarct.
    Carter MD; Lee JH; Buchanan DM; Peterson ED; Tang F; Reid KJ; Spertus JA; Valtos J; O'Keefe JH
    Am J Cardiol; 2010 Jun; 105(12):1651-4. PubMed ID: 20538109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol consumption and risk of heart failure in the Physicians' Health Study I.
    Djoussé L; Gaziano JM
    Circulation; 2007 Jan; 115(1):34-9. PubMed ID: 17130341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study.
    Fosbøl EL; Seibaek M; Brendorp B; Moller DV; Thune JJ; Gislason GH; Torp-Pedersen C; Køber L;
    Int J Cardiol; 2010 Apr; 140(3):279-86. PubMed ID: 19095316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
    Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
    Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.